In vitro oral drug permeation models: the importance of taking physiological and physico-chemical factors into consideration

References

• Balimane PV, Chong S. Cell culture-based models for intestinal permeability. Drug Discov Today. 2005;10:335–343.
   PubMed Web of Science ®Google Scholar
• Lipinski CA, Lombardo F, Dominy BW, et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 1997;23:3–25.
   Web of Science ®Google Scholar
• Ashford M. Assessment of biopharmaceutical properties. New York: Churchill Livingstone; 2008.
   Google Scholar
• Sarmento B, Andrade F, Da Silva SB, et al. Cell-based in vitro models for predicting drug permeability. Expert Opin Drug Metab Toxico. 2012;8:607–621.
   PubMed Web of Science ®Google Scholar
• Koziolek M, Grimm M, Schneider F, et al. Navigating the human gastrointestinal tract for drug delivery: uncharted waters and new frontiers. Adv Drug Deliv Rev. 2016. doi:10.1016/j.addr.2016.03.009.
   PubMed Web of Science ®Google Scholar
• Wrzesinski K, Fey SJ. From 2d to 3d - A new dimension for modelling the effect of natural products on human tissue. Curr Pharm Des. 2015;21:1–12.
   PubMed Web of Science ®Google Scholar
• Elsheikh MA, Elnaggar YSR, Abdallah OY. Rationale employment of cell culture versus conventional techniques in pharmaceutical appraisal of nanocarriers. J Control Release. 2014;194:92–102.
   PubMed Web of Science ®Google Scholar
• Jin X, Luong TL, Reese N, et al. Comparison of MDCK-MDR1 and Caco-2 cell based permeability assays for anti-malarial drug screening and drug investigations. J Pharmacol Toxicol Methods. 2014;70:186–194.
   Web of Science ®Google Scholar
• Le Ferrec E, Chesne C, Artusson P, et al. In vitro models of the intestinal barrier. Altern Lab Anim. 2001;29:649–668.
   PubMed Web of Science ®Google Scholar
• Zeller P, Bricks T, Vidal G, et al. Multiparametric temporal analysis of the Caco-2/TC7 demonstrated functional and differentiated monolayers as early as 14 days of culture. Eur J Pharm Sci. 2015;72:1–11.
   PubMed Web of Science ®Google Scholar
• Pereira C, Araújo F, Barrias CC, et al. Dissecting stromal-epithelial interactions in a 3D in vitro cellularized intestinal model for permeability studies. Biomaterials. 2015;56:36–45.
   PubMed Web of Science ®Google Scholar
• Fitzgerald KA, Malhotra M, Curtin CM, et al. Life in 3D is never flat; 3D models to optimise drug delivery. J Control Release. 2015;215:39–54.
   PubMed Web of Science ®Google Scholar
• Westerhout J, Van De Steeg E, Grossouw D, et al. A new approach to predict human intestinal absorption using porcine intestinal tissue and biorelevant matricies. Eur J Pharm Sci. 2014;63:167–177.
   PubMed Web of Science ®Google Scholar
• Alqatani S, Loqman AM, Kaddoumi A. Experimental models for predicting drug absorption and metabolism. Expert Opin Drug Metab Toxicol. 2013;9:1–10.
   PubMed Web of Science ®Google Scholar
• Annaert P, Brouwers J, Bijnens A, et al. Ex vivo permeability experiments in excised rat intestinal tissue and in vitro solubility measurements in aspirated human intestinal fluids support age-dependent oral drug absorption. Eur J Pharm Sci. 2010;39:15–22.
   PubMed Web of Science ®Google Scholar
• Da Silva LC, Da Silva TL, Antunes AH, et al. A sensitive medium-throughput method to predict intestinal absorption in humans using rat intestinal tissue segments. J Pharm Sci. 2015;104:2807–2812.
   PubMed Web of Science ®Google Scholar
• Lennernäs H. Animal data: The contributions of the ussing chamber and perfusion systems to predicting human oral drug delivery in vivo. Adv Drug Deliv Rev. 2007;59:1103–1120.
   PubMed Web of Science ®Google Scholar
• Rozenhal V, Daisuke N, Hoepner U, et al. Human small intestine and colonic tissue mounted in the ussing chamber as a tool for characterising the intestinal absorption of drugs. Eur J Pharm Sci. 2012;46:367–373.
   PubMed Web of Science ®Google Scholar
• Jung EC, Maibach HI. Animal models for percutaneous absorption. J Appl Toxicol. 2015;35:1–10.
   PubMed Web of Science ®Google Scholar
• Larese FR, D’Agostin F, Crosera M, et al. Human skin penetration of silver nanoparticles through intact and damaged skin. Toxicology. 2009;255:33–37.
   PubMed Web of Science ®Google Scholar
• Herbig ME, Houdek P, Gorissen S, et al. A custom tailored model to investigate skin penetration in porcine skin and its comparison with human skin. Eur J Pharm Biopharm. 2015;95:99–109.
   PubMed Web of Science ®Google Scholar
• Barr WJ, Riegelman S. Intestinal drug absorption and metabolism I: comparison of methods and models to study physiological factors of in vitro intestinal absorption. J Pharm Sci. 1970;59(2):154–163.
   PubMed Web of Science ®Google Scholar
• Yu Q, Wang Z, Li P, et al. The effect of various absorption enhancers on tight junction in the human intestinal Caco-2 cell line. Drug Dev Ind Pharm. 2013;39(4):587–592.
   PubMed Web of Science ®Google Scholar
• Deferme S, Annaert P, Augustijns P. In vitro screening models to assess intestinal drug absorption and metabolism. In: Ehrhardt C, Kim KJ, editors. Drug absorption studies. New York: Springer; 2008.
   Google Scholar
• Versantvoort CHM, Rompelberg CJM, Sips AJAM. Methodologies to study human intestinal absorption. A review. NIPHE. 2000;1–55.
   Google Scholar
• Smithson KW, Millar DB, Jacobs LR, et al. Intestinal diffusion barrier; unstirred water layer of membrane surface mucous coat? Science. 1981;143:1241–1244.
   Web of Science ®Google Scholar
• Ghosh A, Scott DO, Maurer TS. Towards a unified model of passive drug permeation I: origins of the unstirred water layer with applications to ionic permeation. Eur J Pharm Sci. 2014;52:109–124.
   PubMed Web of Science ®Google Scholar
• Ward PD, Tippin TK, Thakker DR. Enhancing paracellular permeability by modulating epithelial tight junctions. PSTT. 2000;3(10):346–358.
   PubMedGoogle Scholar
• Sigurdson HH, Kirch J, Lehr CM. Mucus as a barrier to lipophilic drugs. Int J Pharm. 2013;453:56–64.
   PubMed Web of Science ®Google Scholar
• Haegesaether E, Hiorth M, Ande SA. Mucoadhesion and drug permeability of free mixed film of pectin and chitosan: an in vitro and ex vivo study. Eur J Pharm Biopharm. 2009;71:325–331.
   PubMed Web of Science ®Google Scholar
• Aurajo F, Sarmento B. Towards the characterisation of an in vitro triple co-culture intestine call model for permeability studies. Int J Pharm. 2013;458:128–134.
   PubMed Web of Science ®Google Scholar
• Rocha RA, Vélez D, Devesa V. In vitro evaluation of intestinal fluoride absorption using different cell models. Toxicol Lett. 2012;210:311–317.
   PubMed Web of Science ®Google Scholar
• Hagesaether E, Chrisriansen E, Due-Hansen ME, et al. Mucus can change the permeation rank order of drug candidates. Int J Pharm. 2013;452:276–282.
   PubMed Web of Science ®Google Scholar
• Milotti G, Laffleur F, Perera G, et al. In vivo evaluation of thiolated chitosan tablet for oral insulin delivery. J Pharm Sci. 2014;103:3165–3170.
   PubMed Web of Science ®Google Scholar
• Netsomboon K, Bernkop-Schnürch A. Mucoadhesive vs. mucopenetrating drug delivery. Eur J Pharm Biopharm. 2016;98:76–89.
   PubMed Web of Science ®Google Scholar
• Kondoh M, Masuyama A, Takahashi A, et al. A novel strategy for the enhancement of drug absorption using a claudin modulator. Mol Pharmacol. 2005;67:749–756.
   PubMed Web of Science ®Google Scholar
• Kawauchiya T, Takumi R, Kudo Y, et al. Correlation between the destruction of tight junction by patulin treatment and increase of phosphorylation of ZO-1 in Caco-2 human colon cancer cells. Toxicol Lett. 2011;205:196–202.
   PubMed Web of Science ®Google Scholar
• Anderson JM, Van Itallie CM. Physiology and function of the tight junction. Cold Spring Harb Perspect Biol. 2009;1:a002584.
   PubMed Web of Science ®Google Scholar
• Hilgendorf C, Spahn-Langguth H, Regårdh CG, et al. Caco-2 versus Caco-2/HTX-29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport. J Pharm Sci. 2000;89:63–75.
   PubMed Web of Science ®Google Scholar
• Pelkonen O, Boobis AR, Gundert-Remy U. In vitro prediction of gastrointestinal absorption and bioavailibility: an experts’ meeting report. Eur J Clin Pharmacol. 2001;57:621–629.
   PubMed Web of Science ®Google Scholar
• Englund G, Rorsman F, Rönnblom A, et al. Regional levels of drug transporters along the human intestinal tract: co-expression of ABC and SLC transporters and comparison with Caco-2 cells. Eur J Pharm Sci. 2006;29:269–277.
   PubMed Web of Science ®Google Scholar
• Seithel A, Karlsson J, Hilgendorf C, et al. Variability in mRNA expression of ABC- and SLC-transporters in human intestinal cells: comparison between human segments and Caco-2 cells. Eur J Pharm Sci. 2006;28:291–299.
   PubMed Web of Science ®Google Scholar
• Gartzke D, Fricker G. Establishment of optimized MDCK cell lines for reliable efflux transport studies. J Pharm Sci. 2014;103:1298–1304.
   PubMed Web of Science ®Google Scholar
• Sjogren E, Abrahamsson B, Augustijns P, et al. In vivo methods for drug absorption – comparative physiologies, model selection, correlations with in vitro methods (IVIVC), and applications for formulation/API/excipient characterisation including food effect. Eur J Pharm Sci. 2014;57:99–151.
   PubMed Web of Science ®Google Scholar
• Dalgaard L. Comparison of minipig, dog, monkey and human drug metabolism and disposition. J Pharmacol Toxicol Methods. 2015;74:80–92.
   PubMed Web of Science ®Google Scholar
• Dressman JB, Amidon GL, Reppas C, et al. Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms. Pharm Res. 1998;15:11–22.
   PubMed Web of Science ®Google Scholar
• Markopoulos C, Thoenen F, Preisig D, et al. Biorelevant media for transport experiments in the Caco-2 model to evaluate drug absorption in the fasted and fed state and their usefulness. Eur J Pharm Biopharm. 2014;86:438–448.
   PubMed Web of Science ®Google Scholar
• Wuyts B, Riethorst D, Brouwers J, et al. Evaluation of fasted and fed state simulated and human intestinal fluids as solvent system using the Ussing chamber model to explore food effects on intestinal permeability. Int J Pharm. 2015;478:736–744.
   PubMed Web of Science ®Google Scholar
• Stappaerts J, Wuyts B, Tack J, et al. Human and simulated intestinal fluid as solvent systems to explore food effect on intestinal solubility and permeability. Eur J Pharm Sci. 2014;63:176–786.
   Web of Science ®Google Scholar
• Patel N, Forbes B, Eskola S, et al. Use of simulated intestinal fluids with Caco-2 cells and rat ileum. Drug Dev Ind Pharm. 2006;32:151–161.
   PubMed Web of Science ®Google Scholar
• Fuchs A, Leigh M, Kloefer B, et al. Advances in the design of fasted state simulating intestinal fluids: FaSSIF-V3. Eur J Pharm Biopharm. 2015;94:229–240.
   PubMed Web of Science ®Google Scholar
• Ingels F, Beck B, Oth M, et al. Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers. Int J Pharm. 2004;274:221–232.
   PubMed Web of Science ®Google Scholar
• Yu LX, Lipkab E, Crisonb JR, et al. Transport approaches to the biopharmaceutical design of oral drug delivery systems: prediction of intestinal absorption. Adv Drug Deliv Rev. 1996;19:359–376.
   PubMed Web of Science ®Google Scholar
• Tian S, Wang J, Li Y, et al. The application of in silico drug-likeness predictions in pharmaceutical research. Adv Drug Deliv Rev. 2015;86:2–10.
   PubMed Web of Science ®Google Scholar
• Lipinski CA, Lombardo F, Dominy BW, et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2012;64:4–17.
   Web of Science ®Google Scholar
• Gleeson MP, Hersey A, Montanari D, et al. Probing the links between in vitro potency, ADMET and physicochemical parameters. At Rev Drug Discov. 2011;10:197–208.
   PubMed Web of Science ®Google Scholar
• Bergström CAS, Andersson SBE, Fagerberg JH, et al. Is the full potential of the biopharmaceutics classification system reached? Eur J Pharm Sci. 2014;57:224–231.
   PubMed Web of Science ®Google Scholar
• Gan LL, Thakker DR. Applications of the Caco-2 model in the design and development of orally active drugs: elucidation of biochemical and physical barriers posed by the intestinal epithelium. Adv Drug Deliv Rev. 1997;23:77–98.
   Web of Science ®Google Scholar
• Daugherty AL, Mrsny RJ. Transcellular uptake mechanisms of the intestinal epithelial barrier part one. PSTT. 1999;2(4):144–151.
   Google Scholar
• Krämer SD, Aschmann HE, Hatibovic M, et al. When barriers ignore the “rule-of-five”. Adv Drug Deliv Rev. 2016. doi:10.1016/j.addr.2016.02.001.
   PubMed Web of Science ®Google Scholar
• Shangvi T, Ni N, Mayersohn M, et al. Predicting passive intestinal absorption using a single parameter. QSAR Comb Sci. 2000;22:247–257.
   Google Scholar
• Yalkowsky SH, Johnson JLH, Sanghvi T, et al. A ‘rule of unity’ for human intestinal absorption. Pharm Res. 2006;23(10):2475–2481.
   PubMed Web of Science ®Google Scholar
• Chillistone S, Hardman JG. Factors affecting drug absorption and distribution. Anaesth Intens Care. 2014;15(7):309–313.
   Google Scholar
• Reddy KVR, Reddy V, Loya PC. Molecular aspects of BBB. RJPDFT. 2014;6(2):105–109.
   Google Scholar
• Van de Waterbeemd H. Intestinal permeability: prediction from theory. New York: Marcel Dekker; 2000.
   Google Scholar
• Veber DF, Johnson SR, Cheng H, et al. Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem. 2002;45:2615–2623.
   PubMed Web of Science ®Google Scholar
• Camenisch G, Alsenzc J, van de Waterbeemd H, et al. Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs’ lipophilicity and molecular weight. European J Pharm Sci. 1998;6:313–319.
   Web of Science ®Google Scholar
• Testa B, Crivori P, Reist M, et al. The influence of lipophilicity on the pharmacokinetic behavior of drugs: concepts and examples. Perspect Drug Discov. 2000;19:179–211.
   Google Scholar
• Liu R, Zhou D. Using molecular fingerprint as descriptors in the QSPR study of lipophilicity. J Chem Inf Model. 2008;48:542–549.
   PubMed Web of Science ®Google Scholar
• Yang Y, Engkvist O, Llinàs A, et al. Beyond size, ionization state, and lipophilicity: influence of molecular topology on absorption, distribution, metabolism, excretion, and toxicity for druglike compounds. J Med Chem. 2012;55:3667–3677.
   PubMed Web of Science ®Google Scholar
• Sawant PD, Luu D, Ye R, et al. Drug release from hydroethanolic gels: effect of drug’s lipophilicity (log P), polymer-drug interactions and solvent lipophilicity. Int J Pharm. 2010;396:45–52.
   PubMed Web of Science ®Google Scholar
• Loftsson T. Excipient pharmacokinetics and profiling. Int J Pharm. 2015;480:48–54.
   PubMed Web of Science ®Google Scholar
• Dressman JB, Thelink K, Jantratid E. Towards quantitative prediction of oral drug absorption. Clin Pharmacokinet. 2008;47(10):656–667.
   Web of Science ®Google Scholar
• Varma MVS, Perumal OP, Panchagnula R. Functional role of P-glycoprotein in limiting peroral drug absorption: optimizing drug delivery. Curr Opin Chem Biol. 2006;10:367–373.
   PubMed Web of Science ®Google Scholar
• Hurst S, Loi C, Brodfuehrer J, et al. Impact of physiological, physicochemical and biopharmaceutical factors in absorption and metabolism mechanisms on the drug oral bioavailability of rats and humans. Expert Opin Drug Metab Toxicol. 2007;3(4):469–489.
   PubMed Web of Science ®Google Scholar
• Milletti F, Storchi L, Sforna G, et al. New and original pKa prediction method using grid molecular interaction fields. J Chem Inf Model. 2007;47:2172–2181.
   PubMed Web of Science ®Google Scholar
• Savjani KT, Gajjar AK, Savjani JK. Drug solubility: Importance and enhancement techniques. ISRN Pharm. 2012;2012:1–10.
   Google Scholar
• Lobell M, Hendrix M, Hinzen B, et al. In silico ADMET traffic lights as a tool for the prioritization of HTS hits. Chem Med Chem. 2006;1:1229–1236.
   Web of Science ®Google Scholar
• Ritchie TJ, Ertl P, Lewis R. The graphical representation of ADME-related molecule properties for medicinal chemists. Drug Discov Today. 2011;16:65–72.
   PubMed Web of Science ®Google Scholar